Myriad Genetics
Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties.

Year Established: 1991
Stock Ticker: MYGN
Exchange: NASDAQ